Team

The team at Antidote Europe is comprised of scientists, with Claude Reiss as its president.

Dr Claude Reiss

For more than thirty years, Claude Reiss held the position of research director at the CNRS (French National Centre for Scientific Research) and also conducted research at the Jacques Monod Institute. In addition, he taught biology to doctoral students at the University of Lille. He has now retired from his positions in the public sector and is currently conducting his own research as a personal venture in the private sector.

Dr André Ménache

CEO of Antidote Europe, André Ménache is a zoologist and a veterinary surgeon. He has a particular interest in medical law and was instrumental in amending the Declaration of Helsinki.

Ms Hélène Sarraseca

Hélène Sarraseca is Antidote Europe’‘s administrative director and also co-founder. She is responsible for all correspondence with members, administrative duties, and editing the quarterly publication, “La Notice d’‘Antidote”.

Ms Augustine Savy

Augustine Savy, formerly an assistant-director, is currently retired. A founder member of Antidote Europe, she is very active in promoting the aims of the organisation.

Dr Francoise Reiss

Françoise Reiss is emeritus research director at the CNRS and an internationally recognised figure in the field of bacterial photosynthesis.



News

Are animal models predictive?

7 December 2011: There are many ways in which animals are used in science, but their role as models for predicting human outcome is especially controversial. Read ‘Are animal models predictive for humans?’  by Niall Shanks, Ray Greek and Jean Greek, originally published in Philosophy, Ethics,

Autism: where are we heading?

22 March 2011: The prevalence of autism is growing too quickly for it to be a genetic disorder. Instead, autism is probably caused by exposure of the fetus to harmful substances. [article computer-translated from the French] The causes of autism are to be

Tap water: you said “potable”?

25 December 2010: Tap water is deemed safe to drink if the concentration of dangerous chemicals within it does not reach a certain threshold. But these thresholds are simplistic, outdated and irrelevant. [article computer-translated from the French] Tap water may be subject to

500 deaths in France linked to “Mediator” drug

25 November 2010: The diabetes drug fiasco illustrates what happens when regulatory authorities allow the pharmaceutical industry to test drug safety by “cherry picking” animal species. The diabetes drug “Mediator” is another unfortunate example of what happens when regulatory authorities allow the pharmaceutical

Canada considers BPA toxic

15 October 2010: The Canadian government has issued a final order classifying bisphenol A (BPA) as a toxic substance to be added to Schedule 1 of the Canadian Environmental Protection Act (CEPA). With this, Canada leads the world in protecting the public health